| scholarly article | Q13442814 |
| P50 | author | Sebastian Schneeweiss | Q60162120 |
| Daniel H Solomon | Q91503755 | ||
| P2093 | author name string | Jun Liu | |
| Seoyoung C Kim | |||
| P2860 | cites work | Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data | Q30664587 |
| Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States | Q33568262 | ||
| C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort | Q33605095 | ||
| Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study | Q33789578 | ||
| Validation of rheumatoid arthritis diagnoses in health care utilization data | Q33827617 | ||
| Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis | Q34182804 | ||
| Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden | Q34236174 | ||
| Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity | Q34238357 | ||
| Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases | Q34439990 | ||
| The epidemiology of venous thromboembolism. | Q35157791 | ||
| A review of uses of health care utilization databases for epidemiologic research on therapeutics | Q36111277 | ||
| Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? | Q36327186 | ||
| Determining the test characteristics of claims-based diagnostic codes for the diagnosis of venous thromboembolism in a medical service claims database | Q37847123 | ||
| Pulmonary embolism and deep vein thrombosis | Q38001827 | ||
| Autoimmune diseases and venous thromboembolism: a review of the literature. | Q38039441 | ||
| Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study | Q41729173 | ||
| Etanercept and venous thromboembolism: a case series | Q42917322 | ||
| The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study. | Q43488992 | ||
| Activation of coagulation after administration of tumor necrosis factor to normal subjects | Q43690695 | ||
| Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation | Q46433523 | ||
| Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism | Q46738208 | ||
| Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). | Q47923995 | ||
| A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. | Q50549660 | ||
| Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: a population-based case-control study | Q57300203 | ||
| Physician practices in the management of venous thromboembolism: a community-wide survey | Q67581306 | ||
| Risk factors for venous thromboembolism | Q73548120 | ||
| Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects | Q73628316 | ||
| Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study | Q74208452 | ||
| The relationship between inflammation and venous thrombosis. A systematic review of clinical studies | Q81094196 | ||
| Risk of venous thromboembolism with rheumatoid arthritis | Q83162699 | ||
| Venous and arterial thromboembolic events in adalimumab-treated patients with antiadalimumab antibodies: a case series and cohort study | Q83753675 | ||
| Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP) | Q84637463 | ||
| Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization | Q87405670 | ||
| P433 | issue | 10 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| venous thromboembolism | Q9397786 | ||
| P1104 | number of pages | 8 | |
| P304 | page(s) | 1600-1607 | |
| P577 | publication date | 2013-10-01 | |
| P1433 | published in | Arthritis Care and Research | Q15754720 |
| P1476 | title | Risk of venous thromboembolism in patients with rheumatoid arthritis | |
| P478 | volume | 65 |
| Q34392922 | A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases |
| Q33706485 | Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study. |
| Q88917533 | Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis |
| Q91884309 | Coagulopathies and inflammatory diseases: '…glimpse of a Snark' |
| Q35447619 | Determinants of venous thromboembolism among hospitalizations of US adults: a multilevel analysis |
| Q99608877 | Effect of Moxibustion on Inflammatory Cytokines in Animals with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis |
| Q36211908 | Incidence of Deep Vein Thrombosis and Venous Thromboembolism following TKA in Rheumatoid Arthritis versus Osteoarthritis: A Meta-Analysis |
| Q89534420 | JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors |
| Q89251090 | Optimizing Rheumatoid Arthritis Patients for Surgery |
| Q92464625 | Perioperative medical management for patients with RA, SPA, and SLE undergoing total hip and total knee replacement: a narrative review |
| Q38359475 | Postoperative risk of venous thromboembolism in rheumatic disease patients |
| Q58093382 | Prevalence and risk factors of deep venous thrombosis in patients with longitudinally extensive transverse myelitis: one center data from China |
| Q38819355 | Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study. |
| Q38178528 | Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis |
| Q40091147 | Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs |
| Q92295161 | Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response |
| Q64070213 | Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study |
| Q34378694 | Superior mesenteric vein thrombosis as an early presentation of myelodysplastic syndrome: a case report |
| Q88020354 | The Development of Acute Systemic Multiple Thrombosis after Achieving Remission during Systemic Glucocorticoid Therapy for Acquired Hemophilia A |
| Q54123341 | Thromboembolism with Janus Kinase (JAK) Inhibitors for Rheumatoid Arthritis: How Real is the Risk? |
| Q90623544 | Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme |
Search more.